Blincyto 38.5 mcg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
7680656540018
CH-65654
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Associated product:
BLINCYTO subst sèche 38.5 mcg flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
38.5 UG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
SOLV
|
18.35 MG | Substance | HBESI |
|
PRC
|
1.5 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2520.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2017
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 65654
- Drug name
- Blincyto, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FX07
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 25/02/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- BLINCYTO subst sèche 38.5 mcg flac
- Description (DE)
- BLINCYTO Trockensub 38.5 mcg Durchstf
- Market launch
- 25/02/2016
- Narcotic (BTM)
- No